SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-080944
Filing Date
2022-12-19
Accepted
2022-12-19 16:31:30
Documents
2
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea170495-6k_altamira.htm 6-K 12795
2 PRESS RELEASE, DATED AS OF DECEMBER 19, 2022 ea170495ex99-1_altamira.htm EX-99.1 23295
  Complete submission text file 0001213900-22-080944.txt   37440
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 221471509
SIC: 2834 Pharmaceutical Preparations